Cervical Discogenic Pain Treatment with Percutaneous Jellified Ethanol: Preliminary Experience

Table 1

Demographic, disc level, and visual analogue scale (VAS) score data of the patients who were treated with percutaneous DiscoGel®.

	Age	Gender	Disc level	Pretreatment VAS	6-week posttreatment VAS	3-month posttreatment VAS
	54	F	C4/C5, C5/C7	9.1	2.6	2.8
	51	F	C4/C5, C5/C6	7.7	2.2	2.9
	50	M	C4/C5, C5/C6	9	2.5	3.2
	41	F	C4/C5, C5/C6	8.8	1.4	2.3
	48	F	C5/C6	8.2	2.3	3.1
	32	F	C4/C5, C5/C6	7.8	3.9	4.4
	50	M	C5/C6, C6/C7	8.6	1.5	1.8
	43	F	C6/C7	6.7	1.4	2.3
	59	M	C4/C5, C5/C6	6.5	2.5	3
	51	M	C6/C7	7.3	1.5	3
Mean	47.9			7.97	2.1777778	2.8777778
Standard deviation	7.5490985			0.931009	0.8288211	0.7361688